Taro Pharmaceuticals U.S.A., Inc. has recalled 768 tubes of Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05% (15 g tubes). This prescription antifungal and steroid cream is used to treat fungal skin infections. The recall was issued because testing of a stability sample showed inconsistent levels of Betamethasone Dipropionate (the steroid component), meaning the product failed content uniformity specifications.
Inconsistent levels of the active steroid ingredient could lead to the medication being less effective than intended or having a different potency than prescribed. No incidents or injuries have been reported to date.
You have 2 options:
Quantity: 768 tubes
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.